Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
GSTC
GlobeStar Therapeutics
$0.00
$0.00
$0.00
N/A2.458,020 shsN/A
Histogen Inc. stock logo
HSTO
Histogen
$0.00
$0.02
$0.05
$0.55
$1K1.1910,369 shs40 shs
Propanc Biopharma Inc stock logo
PPCB
Propanc Biopharma
$4.25
+2.4%
$3.91
$1.25
$145.46
$80K2.521,777 shs2,353 shs
Universe Pharmaceuticals INC stock logo
UPC
Universe Pharmaceuticals
$3.85
+0.8%
$4.51
$2.51
$2,592.00
$166K1.43176,577 shs3,420 shs
These 7 Stocks Will Be Magnificent in 2025 Cover

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
GSTC
GlobeStar Therapeutics
0.00%0.00%0.00%-50.00%-87.50%
Histogen Inc. stock logo
HSTO
Histogen
0.00%-97.00%-72.73%-98.97%-99.85%
Propanc Biopharma Inc stock logo
PPCB
Propanc Biopharma
0.00%+2.41%-23.84%-19.05%+386,263.64%
Universe Pharmaceuticals INC stock logo
UPC
Universe Pharmaceuticals
0.00%+5.48%-8.33%+11.59%-99.80%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
GSTC
GlobeStar Therapeutics
N/AN/AN/AN/AN/AN/AN/AN/A
Histogen Inc. stock logo
HSTO
Histogen
N/AN/AN/AN/AN/AN/AN/AN/A
Propanc Biopharma Inc stock logo
PPCB
Propanc Biopharma
N/AN/AN/AN/AN/AN/AN/AN/A
Universe Pharmaceuticals INC stock logo
UPC
Universe Pharmaceuticals
N/AN/AN/AN/AN/AN/AN/AN/A
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
GSTC
GlobeStar Therapeutics
0.00
N/AN/AN/A
Histogen Inc. stock logo
HSTO
Histogen
0.00
N/AN/AN/A
Propanc Biopharma Inc stock logo
PPCB
Propanc Biopharma
0.00
N/AN/AN/A
Universe Pharmaceuticals INC stock logo
UPC
Universe Pharmaceuticals
0.00
N/AN/AN/A
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
GSTC
GlobeStar Therapeutics
N/AN/AN/AN/AN/AN/A
Histogen Inc. stock logo
HSTO
Histogen
$19K0.07N/AN/A$3.13 per share0.00
Propanc Biopharma Inc stock logo
PPCB
Propanc Biopharma
N/AN/AN/AN/A($493.34) per shareN/A
Universe Pharmaceuticals INC stock logo
UPC
Universe Pharmaceuticals
$23.02M0.01N/AN/A$163.50 per share0.02
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
GSTC
GlobeStar Therapeutics
-$1.95MN/A0.00N/AN/AN/AN/AN/AN/A
Histogen Inc. stock logo
HSTO
Histogen
-$10.62M-$2.81N/AN/AN/AN/AN/AN/A
Propanc Biopharma Inc stock logo
PPCB
Propanc Biopharma
-$1.82MN/A0.00N/AN/A-3,652.66%-971.09%N/A
Universe Pharmaceuticals INC stock logo
UPC
Universe Pharmaceuticals
-$6.16MN/A0.00N/AN/AN/AN/AN/A

Latest PPCB, UPC, HSTO, and GSTC Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/15/2025Q3 2025
Propanc Biopharma Inc stock logo
PPCB
Propanc Biopharma
N/A-$12.50N/A-$12.50N/AN/A
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
GSTC
GlobeStar Therapeutics
N/AN/AN/AN/AN/A
Histogen Inc. stock logo
HSTO
Histogen
N/AN/AN/AN/AN/A
Propanc Biopharma Inc stock logo
PPCB
Propanc Biopharma
N/AN/AN/AN/AN/A
Universe Pharmaceuticals INC stock logo
UPC
Universe Pharmaceuticals
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
GSTC
GlobeStar Therapeutics
N/AN/AN/A
Histogen Inc. stock logo
HSTO
Histogen
N/AN/AN/A
Propanc Biopharma Inc stock logo
PPCB
Propanc Biopharma
0.01
2.24
2.24
Universe Pharmaceuticals INC stock logo
UPC
Universe Pharmaceuticals
N/AN/AN/A

Institutional Ownership

CompanyInstitutional Ownership
GSTC
GlobeStar Therapeutics
0.01%
Histogen Inc. stock logo
HSTO
Histogen
N/A
Propanc Biopharma Inc stock logo
PPCB
Propanc Biopharma
N/A
Universe Pharmaceuticals INC stock logo
UPC
Universe Pharmaceuticals
0.18%

Insider Ownership

CompanyInsider Ownership
GSTC
GlobeStar Therapeutics
2.50%
Histogen Inc. stock logo
HSTO
Histogen
3.30%
Propanc Biopharma Inc stock logo
PPCB
Propanc Biopharma
0.10%
Universe Pharmaceuticals INC stock logo
UPC
Universe Pharmaceuticals
57.38%
CompanyEmployeesShares OutstandingFree FloatOptionable
GSTC
GlobeStar Therapeutics
11.24 billion1.21 billionNot Optionable
Histogen Inc. stock logo
HSTO
Histogen
204.27 millionN/ANot Optionable
Propanc Biopharma Inc stock logo
PPCB
Propanc Biopharma
120,00019,000Not Optionable
Universe Pharmaceuticals INC stock logo
UPC
Universe Pharmaceuticals
22043,000731,000Not Optionable

Recent News About These Companies

UPC’s Unexpected Plunge: What’s Next?
Universe Pharmaceuticals gets Nasdaq delisting notice
Universe Pharmaceuticals Files Registration for 37.5 Million Shares

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines

GlobeStar Therapeutics OTCMKTS:GSTC

GlobeStar Therapeutics Corporation, a clinical stage pharmaceutical company, focuses on developing a patented formulation of drugs for the treatment of multiple sclerosis and other neurodegenerative diseases. It offers Amethyst, a compound intended to treat neurodegeneration. The company was formerly known as AngioSoma, Inc. and changed its name to GlobeStar Therapeutics Corporation in July 2021. GlobeStar Therapeutics Corporation is based in Richland, Washington.

Histogen stock logo

Histogen NASDAQ:HSTO

$0.0003 0.00 (0.00%)
As of 07/3/2025

Histogen Inc., a clinical-stage therapeutics company, focuses on developing clinical and preclinical small molecule pan-caspase and caspase selective inhibitors that protect the body's natural process to restore immune function. The company's product candidates include emricasan for the treatment of acute bacterial skin and skin structure infections, as well as other infectious diseases. Its preclinical product candidates include CTS-2090 and CTS-2096, which are selective small molecule inhibitors of caspase-1 designed for the treatment of various inflammatory diseases. Histogen Inc. was founded in 2007 and is based in San Diego, California. On April 18, 2024, Histogen Inc. filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the Southern District of California.

Propanc Biopharma stock logo

Propanc Biopharma OTCMKTS:PPCB

$4.25 +0.10 (+2.41%)
As of 07/3/2025 12:58 PM Eastern

Propanc Biopharma, Inc., a biopharmaceutical company, develops cancer treatments for patients with pancreatic, ovarian, and colorectal cancer in Australia. It offers PRP, a formulation lead product that is in preclinical phase of development designed to enhance the anti-cancer effects of multiple enzymes. The company has a research collaboration with University of Jaén that undertakes the research activities for POP1 joint drug discovery program; and a joint research and drug discovery program with Universities of Jaén and Granada to investigate the changes in genetic and protein expression that occur in cancer cells. The company was formerly known as Propanc Health Group Corporation and changed its name to Propanc Biopharma, Inc. in April 2017. Propanc Biopharma, Inc. was incorporated in 2007 and is based in Camberwell, Australia.

Universe Pharmaceuticals stock logo

Universe Pharmaceuticals NYSE:UPC

$3.85 +0.03 (+0.79%)
Closing price 07/3/2025 03:17 PM Eastern
Extended Trading
$3.81 -0.04 (-1.14%)
As of 07/3/2025 04:58 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Universe Pharmaceuticals INC, through its subsidiaries, engages in the manufacture, marketing, distribution, and sale of traditional Chinese medicine derivative products in China. It offers products for the treatment and relief of common chronic health conditions in the elderly for physical wellness and longevity; and cold and flu medications. The company also distributes and sells third-party products, including biomedical drugs, medical instruments, traditional Chinese medicine pieces, and dietary supplements. Its customers include pharmaceutical companies, hospitals, clinics, and drugstore chains. The company was founded in 1998 and is based in Ji'An, China. Universe Pharmaceuticals INC operates as a subsidiary of Sununion Holding Group Limited.